BioMarin Pharmaceuticals

BMRN

Börsenwert 10,9 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
301	301 Quadrature Capital London, United Kingdom	816.873 $	+262.054 $	+4.784	+50 %
302	302 Raiffeisen Bank International Vienna, Austria	807.380 $	–	–	–
303	303 Concurrent Investment Advisors Tampa, Florida	807.146 $	+359.995 $	+6.572	+87 %
304	304 ProShare Advisors Bethesda, Maryland	798.791 $	-128.671 $	-2.349	-14 %
305	305 Allstate Corporation Northbrook, Illinois	797.418 $	-744.421 $	-13.590	-49 %
306	306 &Partners Nashville, Tennessee	777.791 $	+255.426 $	+4.663	+54 %
307	307 GAMCO Investors Greenwich, Connecticut	743.860 $	-8.217 $	-150	-1 %
308	308 Sequoia Financial Advisors Akron, Ohio	732.188 $	+290.593 $	+5.305	+71 %
309	309 Chicago Partners Investment Group Chicago, Illinois	712.857 $	-4.054 $	-74	-0,6 %
310	310 Linden Thomas Advisory Services Charlotte, North Carolina	702.490 $	-1.424 $	-26	-0,2 %
311	311 Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan	698.084 $	–	–	–
312	312 Kentucky Retirement Systems Frankfort, Kentucky	686.754 $	+657.435 $	+12.002	Neu
313	313 denkapparat Operations Berlin, Germany	683.092 $	–	–	–
314	314 Bleakley Financial Group Fairfield, New Jersey	680.460 $	+651.409 $	+11.892	Neu
315	315 Holocene Advisors New York	668.272 $	–	–	–
316	316 Jupiter Asset Management London, United Kingdom	656.828 $	+628.786 $	+11.479	Neu
317	317 Hantz Financial Services Southfield, Michigan	654.000 $	+4.711 $	+86	+0,8 %
318	318 SBI Okasan Asset Management Tokyo, Japan	651.671 $	–	–	–
319	319 New Age Alpha Advisors Rye, New York	651.164 $	-3,57 Mio. $	-65.115	-85 %
320	320 Dymon Asia Capital (Singapore) Singapore	629.420 $	–	–	–
321	321 Y-Intercept (HK) Hong Kong	628.047 $	-3,69 Mio. $	-67.362	-86 %
322	322 Focus Partners Advisor Solutions Saint Louis, Missouri	623.641 $	-680.934 $	-12.431	-53 %
323	323 Choreo LLC Rockford, Illinois	623.526 $	+22.732 $	+415	+4 %
324	324 Jones Financial Companies Des Peres, Missouri	622.804 $	+288.347 $	+5.264	+99 %
325	325 Meiji Yasuda Life Insurance Tokyo, Japan	598.006 $	–	–	–

BioMarin Pharmaceuticals BMRN Börsenwert 10,9 Mrd. $

BioMarin Pharmaceuticals

BMRN

Börsenwert 10,9 Mrd. $